Hendrik Suhling

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Tuberculous mastitis: A rare manifestation of extrapulmonary tuberculosis

Tuberculous mastitis: A rare manifestation of extrapulmonary tuberculosis

Journal: Pneumologie (Stuttgart, Germany)

Published: April 27, 2026

Relationship between knowledge, adherence-related behaviors and self-management with response to monoclonal antibody therapy in patients with severe asthma.

Relationship between knowledge, adherence-related behaviors and self-management with response to monoclonal antibody therapy in patients with severe asthma.

Journal: Scientific reports

Published: March 10, 2026

Choosing and switching biologics for patients with severe asthma: Real-world data from the German Asthma Net (GAN).

Choosing and switching biologics for patients with severe asthma: Real-world data from the German Asthma Net (GAN).

Journal: Allergologie select

Published: December 01, 2025

B cell activating factor (BAFF) levels are associated with failed remission after 12 months of treatment with benralizumab and mepolizumab in severe asthma.

B cell activating factor (BAFF) levels are associated with failed remission after 12 months of treatment with benralizumab and mepolizumab in severe asthma.

Journal: Respiratory research

Published: September 10, 2025

Long-term outcomes of dupilumab therapy in severe asthma: A retrospective, multicenter, real-world study.

Long-term outcomes of dupilumab therapy in severe asthma: A retrospective, multicenter, real-world study.

Journal: The journal of allergy and clinical immunology. Global

Published: January 20, 2025

Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial.

Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial.

Journal: ERJ open research

Published: April 12, 2024

Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany.

Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany.

Journal: The journal of allergy and clinical immunology. In practice

Published: April 09, 2024

"Crack lung" - atypical bilateral pneumonia

"Crack lung" - atypical bilateral pneumonia

Journal: Innere Medizin (Heidelberg, Germany)

Published: January 16, 2024

The Impact of Smoking History on Baseline Characteristic in Patients With Severe Asthma in the German Asthma Net (GAN).

The Impact of Smoking History on Baseline Characteristic in Patients With Severe Asthma in the German Asthma Net (GAN).

Journal: The journal of allergy and clinical immunology. In practice

Published: December 03, 2023

As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort.

As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort.

Journal: ERJ open research

Published: October 05, 2023

Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS).

Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS).

Journal: Pneumologie (Stuttgart, Germany)

Published: August 25, 2023

Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy.

Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy.

Journal: BMC pulmonary medicine

Published: July 26, 2023

Showing 1-12 of 66

Last Updated: 09/26/2026